Antibiotic-Resistant Plague Returns

A business professional holding a warning sign next to a model of a hospital
AMERICANS' HEALTH AT RISK

Tuberculosis cases surge to a 13-year high in 2024, disproportionately hitting foreign-born Americans amid unchecked migration—echoing failures of open-border policies that conservatives warned would import deadly diseases.

Story Highlights

  • CDC reports over 10,300 TB cases in 2024, up 8% from 2023 and the highest since 2011, driven by migration and post-COVID disruptions.
  • Non-US-born individuals face 15.5 cases per 100,000 vs. 0.8 for US-born, highlighting imported risks from global hotspots.
  • Outbreaks explode in states like Kansas (148% increase), straining local health systems in congregate settings like prisons.
  • Historical “White Plague” threatens resurgence with antibiotic resistance risks, demanding stronger border controls and surveillance.

TB Cases Hit Highest Level Since 2011

CDC preliminary data show 10,388 tuberculosis cases in 2024, an 8% increase from approximately 9,500 in 2023. This resurgence reverses three decades of decline, with cases climbing since 2021 after a 2020 dip due to lockdowns.

Foreign-born individuals account for most cases, at 15.5 per 100,000 in incidence, versus 0.8 per 100,000 for US-born individuals. Conservatives see this as a direct consequence of lax immigration enforcement, importing diseases from high-prevalence regions, and burdening American taxpayers with treatment costs.

Migration and Disruptions Fuel the Spread

Post-pandemic care disruptions delayed diagnoses and treatments, particularly among high-risk groups. International travel and migration surges brought cases from low-resource countries where TB persists. Kansas reported a 148% rate increase, while Alaska and Hawaii topped rates at 12.7 and 8.1 per 100,000.

Congregate settings like prisons and jails amplify transmission, compounded by HIV, malnutrition, and comorbidities common in immigrant communities. This pattern underscores the need for rigorous border health screenings to protect American families.

Disproportionate Impact on High-Risk Groups

TB affects all ages across 34 states and DC, but strikes immigrants, ethnic minorities, the incarcerated, and low-income populations hardest. Latent infections reactivate under immune-weakening conditions, differing from COVID’s acute spread.

University of Utah Health experts call the 2026 situation “unacceptable,” urging congregate screening and funding. Economic fallout includes catastrophic household costs, though every $1 invested yields $43 in returns—yet stigma and poverty perpetuate neglect in vulnerable communities.

Socioeconomic disparities drive the crisis, with experts like Allison Carey pushing for better vaccines beyond outdated BCG and shorter antibiotic regimens. CDC attributes trends to travel, migration, and outbreaks, calling for community engagement and latent TB infection treatment.

Resistance Risks and Path Forward

Treatment involves 3-4 antibiotics over 4-6 months, but multidrug-resistant TB looms if latent cases go untreated. Global cases hovered at 10.7 million in 2024, linking US rises to worldwide travel. World TB Day on March 24, 2026, highlighted gaps in drug-resistant detection.

Conservatives demand accountability: endless spending on global aid ignores domestic threats from unvetted entries, eroding public health sovereignty much like past fiscal mismanagement fueled inflation.

WHO and CDC urge surveillance and interventions, but gaps in funding and screening persist. Innovations in diagnostics like IGRA tests and fluoroquinolones offer hope, yet political will falters. With war draining resources in 2026, prioritizing America First means securing borders against invisible invaders like TB to safeguard conservative values of family and self-reliance.

Sources:

Tuberculosis resurgence review (Sage Journals)

TB socioeconomic disparities analysis (PubMed)

World Tuberculosis Day insights (University of Utah Health)

2026 TB outbreaks and vaccines (Vax-Before-Travel)

Tuberculosis on the rise in US (Pulmonology Advisor)

World TB Day 2026 WHO data (Med-Tech World)

WHO EMRO World TB Day 2026